ALPHA-SYNUKLEIN-PROTOFIBRILL-BINDENDE ANTIKÖRPER

European patent · EP4172199 · In force

Register entry

Publication number
EP4172199
Application number
EP21765693
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 25, 2021
Published
May 3, 2023
Granted
May 14, 2025
Protection ends at the latest
Jun 24, 2041
Next annual fee due
Jun 30, 2027
IPC classes
C07K 16/18 (2006.01)
A61P 25/00 (2006.01)
Priority
US 202063044881 P 26.06.2020
US 202063071150 P 27.08.2020
PCT application
PCT/IB2021/000440 25.06.2021
PCT publication
WO2021/260434 30.12.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Mar 25, 2026

    Change

    Published in Swissreg on 25.03.2026

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Jun 23, 2025

    Agent entered

    Representative
    AWA Switzerland Ltd., Case Postale 47, 2800 Delémont

    Published in Swissreg on 23.06.2025

  5. May 14, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.05.2025

Parties

Holder

BioArctic AB

Warfvinges väg 35, 112 51 Stockholm, SE

Agent

AWA Switzerland SA

AWA Switzerland Ltd.

Case Postale 47, 2800 Delémont

Inventor

NORDSTRÖM, Eva

194 54 Upplands Väsby, SE

SIGVARDSON, Jessica

163 47 Spanga, SE

NYGREN, Patrik

112 58 Stockholm, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.